AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Headline
The Supreme Court June 28 overturned a 1984 ruling in Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., which required courts to defer to…
Headline
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal…
Headline
The Supreme Court June 27 dismissed a case about whether an Idaho law can coexist with the federal Emergency Medical Treatment and Active Labor Act (EMTALA),…
Headline
AHA and the Institute for Diversity and Health Equity recently released the fourth of its five-part DEI Data Insights series, which highlights results from the…
Headline
The U.S. Court of Appeals for the 5th Circuit June 21 partially affirmed the district court judgment that the Preventative Services Task Force charged with…
Headline
Juneteenth reminds us of the enduring legacy of systemic inequities and the ongoing calling to dismantle them, wherever they exist, writes Daniel E. Dawes,…